Literature DB >> 10731621

Tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in the primate cerebellum. Evidence for a lobular- and laminar-specific dopamine innervation.

D S Melchitzky1, D A Lewis.   

Abstract

The cerebellum seems to play a critical role in many motor and cognitive functions, including those that are disturbed in schizophrenia. Although dopamine is known to influence the motor or cognitive functions mediated by other brain regions and to play a role in the pathophysiology of schizophrenia, the cerebellum has not been thought to be a target of dopamine-containing axons. However, given recent reports of dopamine receptors in the cerebellum, we sought to determine whether axons immunoreactive for the proteins involved in dopamine synthesis and reuptake are present in the cerebellum of macaque monkeys. We found that axons immunoreactive for the dopamine membrane transporter, a specific marker of dopamine axons, were present in high density, but only in certain lobules of the cerebellar vermis. In addition, these axons were found principally in the granule cell layer, where they densely arborized immediately subjacent to the Purkinje cells. Similarly, axons labeled for tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis, were also present in high density in the granule cell layer of the same lobules of the vermis. In contrast, axons immunoreactive for dopamine beta-hydroxylase, a marker of noradrenergic axons, exhibited a different and more widespread pattern of innervation. These findings are consistent with a dopamine innervation of the primate cerebellum that is both lobular- and laminar-specific, and they suggest that dopamine may play a role in certain cerebellar functions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10731621     DOI: 10.1016/S0893-133X(99)00139-6

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  42 in total

1.  Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate.

Authors:  Michael Michaelides; Javier Pascau; Juan-Domingo Gispert; Foteini Delis; David K Grandy; Gene-Jack Wang; Manuel Desco; Marcelo Rubinstein; Nora D Volkow; Panayotis K Thanos
Journal:  Eur J Neurosci       Date:  2010-07-16       Impact factor: 3.386

2.  Microarray analysis identifies cerebellar genes sensitive to chronic ethanol treatment in PKCgamma mice.

Authors:  Barbara J Bowers; Richard A Radcliffe; Amy M Smith; Jill Miyamoto-Ditmon; Jeanne M Wehner
Journal:  Alcohol       Date:  2006-08       Impact factor: 2.405

3.  Cortical dopaminergic innervation among humans, chimpanzees, and macaque monkeys: a comparative study.

Authors:  M A Raghanti; C D Stimpson; J L Marcinkiewicz; J M Erwin; P R Hof; C C Sherwood
Journal:  Neuroscience       Date:  2008-05-20       Impact factor: 3.590

4.  Pharmacological characterization and anatomical distribution of the dopamine transporter in the mouse cerebellum.

Authors:  Foteini Delis; Ada Mitsacos; Panagiotis Giompres
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

5.  Reduced dopamine transporter expression in the amygdala of subjects diagnosed with schizophrenia.

Authors:  Matej Markota; Jessica Sin; Harry Pantazopoulos; Rebecca Jonilionis; Sabina Berretta
Journal:  Schizophr Bull       Date:  2014-06-16       Impact factor: 9.306

6.  Predictive Motor Timing and the Cerebellar Vermis in Schizophrenia: An fMRI Study.

Authors:  Jan Lošák; Jitka Hüttlová; Petra Lipová; Radek Marecek; Martin Bareš; Pavel Filip; Jozef Žubor; Libor Ustohal; Jirí Vanícek; Tomáš Kašpárek
Journal:  Schizophr Bull       Date:  2016-05-17       Impact factor: 9.306

7.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

8.  Reversal of the expression pattern of Aldolase C mRNA in Purkinje cells and Ube 1x mRNA in Golgi cells by a dopamine D1 receptor agonist injections in the methamphetamine sensitized-rat cerebellum.

Authors:  Mitsuko Hamamura; Naotsugu Hirata; Kazuhiko Sawada; Takahide Shuto; Takao Shimazoe; Yoshihiro Terada; Yasuyuki Fukumaki
Journal:  J Neural Transm (Vienna)       Date:  2008-02-26       Impact factor: 3.575

9.  Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats.

Authors:  Felipe Schmitz; Emilene B S Scherer; Fernanda R Machado; Aline A da Cunha; Bárbara Tagliari; Carlos A Netto; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2012-09-12       Impact factor: 3.584

10.  Mapping the genetic variation of executive attention onto brain activity.

Authors:  Jin Fan; John Fossella; Tobias Sommer; Yanghong Wu; Michael I Posner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.